Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Instituto Nacional de Cancerologia de Mexico | OTHER |
| Amsterdam UMC, location VUmc | OTHER |
| Pontificia Universidad Catolica de Chile | OTHER |
| Vall d'Hebron Institute of Oncology |
Not provided
Not provided
Not provided
Not provided
This study is divided into two parts:
Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors.
Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori
Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program.
Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| knowledge GC risk factors and symptoms | Compare the results obtained through a knowledge of CG risk factors by study-specific questionnaire before and after an educational intervention | 3 years |
| H. pylori prevalence and drug resistance | Generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at months 6th, 12th, 24th and 36th. | 3 years |
Not provided
Not provided
Part A: Educational Intervention Inclusion criteria
Part B: H. pylori Register Inclusion criteria
Not provided
Not provided
Not provided
Part 1:
Subjects >18 years old whom able to answer the questions structured in the survey.
Part 2:
Subjects >18 years old diagnose from H. pylori infection
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Instituto Alexander Fleming | Buenos Aires | C1426NZ | Argentina | |||
| Pontificia Universidad Católica de Chile |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39939517 | Derived | Carbonell-Asins JA, Jimenez-Marti E, Romero S, Garcia E, Miralles-Marco A, Lopez B, Huerta M, Caballero C, Boggino H, Gauna C, Acevedo-Funes OB, Nunez GB, Cespedes-Cardozo CM, Fernandez-Figueroa EA, Ortiz-Olvera N, Ruiz-Garcia E, Carneiro F, Barros R, Figueiredo C, Ferreira RM, Groen-van Schooten TS, van Santvliet D, Derks S, Luca R, Alsina M, Riquelme A, Cervantes A, Fleitas T. Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium. J Cancer Educ. 2025 Oct;40(5):804-811. doi: 10.1007/s13187-025-02578-2. Epub 2025 Feb 13. | |
| 35692051 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| OTHER |
| INSTITUTO ALEXANDER FLEMING | UNKNOWN |
| Hospital Central del IPS | OTHER |
| IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto | OTHER |
Not provided
Not provided
Not provided
| Santiago |
| 8331150 |
| Chile |
| Instituto Nacional de Cancerología | México | 01480 | Mexico |
| VU Medical Centre | Amsterdam | 1081 | Netherlands |
| GenPat | Asunción | Paraguay |
| Institute of Pathology and Immunology of University of Porto | Porto | 4200 135 | Portugal |
| Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron (VHIO) | Barcelona | 08035 | Spain |
| Fundación Investigación Clínico de Valencia | Valencia | 46010 | Spain |
| Derived |
| van Schooten TS, Derks S, Jimenez-Marti E, Carneiro F, Figueiredo C, Ruiz E, Alsina M, Molero C, Garrido M, Riquelme A, Caballero C, Lezcano E, O'Connor JM, Esteso F, Farres J, Mas JM, Lordick F, Vogt J, Cardone A, Girvalaki C, Cervantes A, Fleitas T; members of LEGACy consortium. The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally. BMC Cancer. 2022 Jun 13;22(1):646. doi: 10.1186/s12885-022-09689-9. |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |